Navigation Links
Novadaq Technologies Notice of Annual Meeting
Date:5/8/2008


TORONTO, May 8 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a developer of real-time imaging and image guidance systems for use in the operating room, will be holding its annual meeting, hosted by Dr. Arun Menawat, President and Chief Executive Officer and Mr. Roger Deck, Chief Financial Officer.

DATE: May 15, 2008

TIME: 9:30 am, Eastern Daylight Time

LOCATION: Saint Andrews Club

150 King Street West

27th Floor

(Northeast Corner of University & King)

Toronto, Ontario, Canada

WEBCAST: A live audio webcast of the call will be available at

http://www.novadaq.com

Webcast attendees are welcome to listen to the

conference in real-time or on-demand at your

convenience. The webcast will be archived for 90 days.

Please connect to this website at least 15 minutes

prior to the conference call to ensure adequate time

for any software download that may be needed to hear

the webcast.

About Novadaq Technologies

Novadaq Technologies Inc. commercializes real-time imaging and image guidance systems for use in the operating room. With one set of proprietary core technologies, Novadaq's products have multiple applications. Novadaq's SPY System enables cardiac surgeons to diagnose intra-operatively by visually assessing coronary vasculature and bypass graft functionality during the course of heart bypass surgery. The SPY System is also indicated for use during other surgeries, such as cardiovascular, plastic, reconstructive, organ transplant and urological procedures. SPY can be used to visualize blood vessels, tumors, tum
'/>"/>

SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novadaq to hold first quarter 2008 results conference call and webcast
2. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast
3. Novadaq to present at Cowen Healthcare Conference
4. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
5. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
6. Novadaqs SPY System receives clearance for use in organ transplant surgery
7. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
8. Novadaq to present at BMO Healthcare Conference
9. Novadaq to present at Piper Jaffray Healthcare Conference
10. Novadaq announces third quarter 2007 conference call and webcast
11. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...class of drugs based on a widely used anticancer d...g effects in the laboratory and in mice, according... interesting for the treatment of these tumors. //...rea were extremely active in blocking the same cel...
... Cipro, Cipro. That's been the mantra of the media...usands who weren't -- clamor for the potent antibi...r cheaper and widely available medications can be ...rug: penicillin. Although alternatives exist, Cipr...
...erimental anti-cancer drug has shown effectiveness...ng to a new report. Researchers say the drug proba...be useful for treating other types of cancer. Dr. ...Bethesda, Maryland, and colleagues tested the drug...
...ox, a highly contagious virus that kills at least ...survive, was eradicated from the globe more than t...variola virus, which causes the disease, and store..., and Moscow, Russia. A smallpox attack is just on...
Other Medicine News:
(Date:9/6/2008)...monstrate Safety and Efficacy of First-in-Class Ne...he Treatment of Acute Migraine, LONDON, Sept. 6 /...nnovative biotechnology company focusing on therap...d Phase II results of its lead compound COL-144,in...ated that COL-144 was,safe and effective in reliev...
(Date:9/5/2008)... Va., Sept. 5 /- CEL-SCI Co...esented new rheumatoid arthritis data,at the Marcu... The data,presented by Dr. Daniel Zimmerman, Seni... of CEL-SCI, indicate that CEL-SCI,s rheumatoid,ar...ermanent tissue damage,caused by rheumatoid arthri...
(Date:9/4/2008)...NE, Australia, Sept. 4 /- Cytopia Lim...ing enrolment for its Phase Ib/II,study of CYT997,...r agent,in patients with an aggressive form of br..., The GBM clinical trial is the first Phase II ef...ations for the company and the second in its,suite...
(Date:9/4/2008)...a Published in ,The Lancet, and Presented at ESC C...esults from a new international,study, the GISSI H...ose of,omega-3 acid ethyl esters reduced all cause...lar reasons in patients with chronic heart,failure...ne version of ,The,Lancet, and were presented at t...
Breaking Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Low Back Disorders Chapter Released 9839 1Low Back Disorders Chapter Released 9839 2Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday February 06 2008 9837 1Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday February 06 2008 9837 2Abortion Opponents in 59 Cities Prepare Focused 40 Day Campaign to Counter Impact of Roe v Wade 9835 1Abortion Opponents in 59 Cities Prepare Focused 40 Day Campaign to Counter Impact of Roe v Wade 9835 2Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 1Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 2Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 3
...26, 2007 - Study results show,that elevated lipopr...diovascular-specific inflammatory enzyme associate...ck and stroke, is,especially predictive of heart d...e--a serious medical condition that affects nearly...sented yesterday,at the American College of Cardio...
...Problem of Antibiotic Resistance,Published in Natu...ch 26, 2007 /PRNewswire/ --,Inimex Pharmaceuticals...e system trigger to cure infections without causin...shed in the April 2007,issue of Nature Biotechnolo...ex and its,co-founders Dr. Bob Hancock and Dr. Bre...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use.
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Medicine Products: